Stem Cells and Their Potential in Cell-Based Cardiac Therapies

Nicolas Christoforou, John D. Gearhart

Research output: Contribution to journalArticle

Abstract

Stem cells are potential agents for the treatment of myocardial infarcts among other heart diseases. Over the past decade, the scientific community has extensively used a wide variety of cells and examined their capacity to both regenerate the infarcted myocardium and improve functionally the diseased hearts. Some of the cells used include skeletal myoblasts, bone marrow-derived cells, adult cardiac resident stem cells, mesenchymal stem cells, and both mouse and human embryonic stem cells (Nat Biotechnol 2005;23:845-856). The reported cardiogenic capacity of the utilitized stem cells is assayed both in vitro through the use of differentiation paradigms and in vivo through transplantation into a variety of animal models of cardiac disease. The purpose of this review article is to summarize recent stem cell applications in cell-based cardiac therapies and their outcomes.

Original languageEnglish (US)
Pages (from-to)396-413
Number of pages18
JournalProgress in Cardiovascular Diseases
Volume49
Issue number6
DOIs
StatePublished - May 2007

Fingerprint

Stem Cells
Heart Diseases
Skeletal Myoblasts
Therapeutics
Mesenchymal Stromal Cells
Bone Marrow Cells
Myocardium
Animal Models
Transplantation
Myocardial Infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Stem Cells and Their Potential in Cell-Based Cardiac Therapies. / Christoforou, Nicolas; Gearhart, John D.

In: Progress in Cardiovascular Diseases, Vol. 49, No. 6, 05.2007, p. 396-413.

Research output: Contribution to journalArticle

Christoforou, Nicolas ; Gearhart, John D. / Stem Cells and Their Potential in Cell-Based Cardiac Therapies. In: Progress in Cardiovascular Diseases. 2007 ; Vol. 49, No. 6. pp. 396-413.
@article{c7ab926fbe2240d88c7cd9df39355a04,
title = "Stem Cells and Their Potential in Cell-Based Cardiac Therapies",
abstract = "Stem cells are potential agents for the treatment of myocardial infarcts among other heart diseases. Over the past decade, the scientific community has extensively used a wide variety of cells and examined their capacity to both regenerate the infarcted myocardium and improve functionally the diseased hearts. Some of the cells used include skeletal myoblasts, bone marrow-derived cells, adult cardiac resident stem cells, mesenchymal stem cells, and both mouse and human embryonic stem cells (Nat Biotechnol 2005;23:845-856). The reported cardiogenic capacity of the utilitized stem cells is assayed both in vitro through the use of differentiation paradigms and in vivo through transplantation into a variety of animal models of cardiac disease. The purpose of this review article is to summarize recent stem cell applications in cell-based cardiac therapies and their outcomes.",
author = "Nicolas Christoforou and Gearhart, {John D.}",
year = "2007",
month = "5",
doi = "10.1016/j.pcad.2007.02.006",
language = "English (US)",
volume = "49",
pages = "396--413",
journal = "Progress in Cardiovascular Diseases",
issn = "0033-0620",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Stem Cells and Their Potential in Cell-Based Cardiac Therapies

AU - Christoforou, Nicolas

AU - Gearhart, John D.

PY - 2007/5

Y1 - 2007/5

N2 - Stem cells are potential agents for the treatment of myocardial infarcts among other heart diseases. Over the past decade, the scientific community has extensively used a wide variety of cells and examined their capacity to both regenerate the infarcted myocardium and improve functionally the diseased hearts. Some of the cells used include skeletal myoblasts, bone marrow-derived cells, adult cardiac resident stem cells, mesenchymal stem cells, and both mouse and human embryonic stem cells (Nat Biotechnol 2005;23:845-856). The reported cardiogenic capacity of the utilitized stem cells is assayed both in vitro through the use of differentiation paradigms and in vivo through transplantation into a variety of animal models of cardiac disease. The purpose of this review article is to summarize recent stem cell applications in cell-based cardiac therapies and their outcomes.

AB - Stem cells are potential agents for the treatment of myocardial infarcts among other heart diseases. Over the past decade, the scientific community has extensively used a wide variety of cells and examined their capacity to both regenerate the infarcted myocardium and improve functionally the diseased hearts. Some of the cells used include skeletal myoblasts, bone marrow-derived cells, adult cardiac resident stem cells, mesenchymal stem cells, and both mouse and human embryonic stem cells (Nat Biotechnol 2005;23:845-856). The reported cardiogenic capacity of the utilitized stem cells is assayed both in vitro through the use of differentiation paradigms and in vivo through transplantation into a variety of animal models of cardiac disease. The purpose of this review article is to summarize recent stem cell applications in cell-based cardiac therapies and their outcomes.

UR - http://www.scopus.com/inward/record.url?scp=34247857550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247857550&partnerID=8YFLogxK

U2 - 10.1016/j.pcad.2007.02.006

DO - 10.1016/j.pcad.2007.02.006

M3 - Article

C2 - 17498520

AN - SCOPUS:34247857550

VL - 49

SP - 396

EP - 413

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

IS - 6

ER -